Related Experiment Videos
Age-dependent (+)MDMA-mediated neurotoxicity in mice
Maria Elena Reveron1, Terrence J Monks, Christine L Duvauchelle
1Division of Pharmacology and Toxicology, College of Pharmacy, University of Texas at Austin, TX 78712, USA.
Neurotoxicology
|July 7, 2005
Summary
Older mice show greater hyperthermic responses and dopaminergic damage after MDMA exposure. This study highlights age-dependent neurotoxicity of MDMA, impacting vesicular monoamine transporter 2 and dopamine transporter levels.
Area of Science:
- Neuroscience
- Pharmacology
- Toxicology
Background:
- (+)-MDMA (Ecstasy) is a recreational drug with known neurotoxic potential.
- Age-related differences in drug metabolism and neurodevelopment can influence vulnerability to neurotoxicants.
Purpose of the Study:
- To investigate the age-dependent effects of a neurotoxic regimen of (+)-MDMA in young (4-week-old) and older (10-week-old) mice.
- To assess hyperthermic responses and dopaminergic system damage following (+)-MDMA administration.
Main Methods:
- C57Bl/6J mice (4- and 10-week-old) received a neurotoxic regimen of (+)-MDMA (20 mg/kgx4, s.c.).
- Rectal temperatures were monitored, and immunoblot analyses were performed for VMAT2, TH, and DAT.
- Striatal dopamine and 3,4-dihydroxyphenylacetic acid levels were quantified.
Main Results:
- Both age groups exhibited hyperthermia, with older mice showing a significantly greater response.
- Older mice displayed significant reductions in VMAT2 and TH, while younger mice did not.
- Dopamine transporter (DAT) expression was reduced in both age groups, more profoundly in older mice.
- Striatal dopamine and its metabolite were significantly decreased, especially in older animals.
Conclusions:
- Older mice are more susceptible to (+)-MDMA-induced hyperthermia and subsequent dopaminergic neurotoxicity.
- Age is a critical factor influencing the severity of (+)-MDMA neurotoxicity, affecting key dopaminergic markers.